|
...Technology. These antigens, previously identified and characterized immunologically by LICR, will add substantially to new Celldex development programs for a range of cancer types. Three of these antigens (NY-ESO-1, MAGE3, and MelanA) are being studied in non-small cell lung, ovarian, and bladder cancers, as well as melanoma, in an extended series of Phase I/II programs conducted by the LICR and its collaborators.
The collaboration will encompass...
NOTE: All illustrations and photos
have been removed from this article.
More articles from BIOTECH Patent News
Oklahoma Medical Research Foundation obtains United States patent., October 01, 2006
Genencor obtains United States patent., October 01, 2006
Nestec S.A. obtains United States patent., October 01, 2006
Genentech obtains United States patent., October 01, 2006
Purdue Research Foundation obtains United States patent., October 01, 2006
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
